Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | BUB1 | O43683 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Verbenone SCHEMBL12914978 | 1.00 | TSHR (0.41) | TSHRMAPK1BUB1 | |
| Verbenone SCHEMBL3506768 | 1.00 | TSHR (0.41) | TSHRMAPK1BUB1 | |
| Verbenone SCHEMBL6562635 | 1.00 | TSHR (0.41) | TSHRMAPK1BUB1 | |
| Verbenone SCHEMBL10615025 | 1.00 | TSHR (0.41) | TSHRMAPK1BUB1 | |
| Verbenone SCHEMBL118161 | 1.00 | TSHR (0.41) | TSHRMAPK1BUB1 | |
| Verbenone SCHEMBL17204705 | 0.91 | TSHR (0.35) | TSHRMAPK1BUB1 | |
| Verbenone SCHEMBL11546159 | 0.83 | TSHR (0.31) | TSHRMAPK1 | |
| Eucalyptol SCHEMBL647135 | 0.80 | TSHR (0.50) | TSHRMAPK1 | |
| SCHEMBL11762192 | 0.74 | BUB1 (0.31) | BUB1 | |
| SCHEMBL18944189 | 0.72 | BUB1 (0.33) | BUB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4651713-A1 | PLANT TREATMENT COMPOSITIONS COMPRISING CHITOSAN-COATED EMULSIONS | Universität Münster (DE) | 2025-11-26 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| CN-119823825-A | Myrtle essential oil and application of compound essential oil based on myrtle essential oil in pest control | 广东海洋大学 | 2025-04-15 | — | — | CN | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| WO-2024153800-A1 | PLANT TREATMENT COMPOSITIONS COMPRISING CHITOSAN-COATED EMULSIONS | UNIVERSITÄT MÜNSTER (DE) | 2024-07-25 | — | — | WO | claimed |
| US-20240165020-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-05-23 | — | — | US | claimed |
| EP-4360653-A2 | LIQUISOFT CAPSULES | Patheon Softgels Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| US-11938242-B2 | Apparatus and method for reducing malodor on surfaces | THE PROCTER & GAMBLE PLAZA (US) | 2024-03-26 | — | — | US | claimed |
| US-11872307-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2024-01-16 | — | — | US | claimed |
| EP-2729136-A1 | DRUG COMBINATIONS AND USES IN TREATING A COUGHING CONDITION | Biocopea Limited (GB) | 2014-05-14 | — | — | EP | claimed |
| EP-2608847-A1 | THEOBROMINE IN COMBINATION WITH AN EXPECTORANT OR A MUCOLYTIC FOR USE IN THERAPY | Biocopea Limited (GB) | 2013-07-03 | — | — | EP | claimed |
| WO-2013004999-A1 | DRUG COMBINATIONS AND USES IN TREATING A COUGHING CONDITION | BIOCOPEA LIMITED (GB) | 2013-01-10 | — | — | WO | claimed |
| WO-2012025761-A1 | THEOBROMINE IN COMBINATION WITH AN EXPECTORANT OR A MUCOLYTIC FOR USE IN THERAPY | BIOCOPEA LIMITED (GB) | 2012-03-01 | — | — | WO | claimed |
| US-20100087455-A1 | SUBSTITUTED XANTHINE COMPOUNDS | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-04-08 | — | — | US | claimed |
| EP-2170825-A2 | SUBSTITUTED INDOLES | Auspex Pharmaceuticals, Inc. (US) | 2010-04-07 | — | — | EP | claimed |
| US-20090203763-A1 | SUBSTITUTED BENZHYDRYLETHERS | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-08-13 | — | — | US | claimed |
| WO-2009094457-A2 | SUBSTITUTED BENZHYDRYLETHERS | AUSPEX PHARMACEUTICALS (US) | 2009-07-30 | — | — | WO | claimed |
| US-20090191183-A1 | SUBSTITUTED INDOLES | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-07-30 | — | — | US | claimed |
| WO-2009018280-A2 | SUBSTITUTED INDOLES | AUSPEX PHARAMACEUTICALS, INC. (US) | 2009-02-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11938242-B2 | Apparatus and method for reducing malodor on surfaces | AOX1, AOC2, AOC1 | TSHR 2457/4885MAPK1 3739/4885BUB1 1656/4885 |
| US-20100087455-A1 | SUBSTITUTED XANTHINE COMPOUNDS | XDH, HPRT1, SLC10A1 | TSHR 3552/4885MAPK1 3541/4885BUB1 4652/4885 |
| US-20090203763-A1 | SUBSTITUTED BENZHYDRYLETHERS | UGT2B7, CYP3A7, CYP3A43 | TSHR 3854/4885MAPK1 4587/4885BUB1 1832/4885 |
| US-20090191183-A1 | SUBSTITUTED INDOLES | CYSLTR1, LTB4R, LTB4R2 | TSHR 606/4885MAPK1 3769/4885BUB1 3612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.